This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
3 mREIT Stock Picks to Navigate Volatile Industry Trends
by Riya Anand
Declining mortgage rates and improving purchase originations are poised to benefit the Zacks REIT and Equity Trust industry. Amid this, industry players like ARR, RWT and IVR are poised to flourish.
MFA Financial Gears Up to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
MFA's third-quarter 2024 results are likely to reflect the benefits of loan demand. Declines in earnings assets are expected to have offset growth.
Invesco Mortgage Capital (IVR) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Invesco Mortgage Capital (IVR) closed at $8.06, marking a -0.12% move from the previous day.
INVESCO MORTGAGE CAPITAL INC (IVR) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Invesco Mortgage Capital (IVR). This makes it worthwhile to examine what the stock has in store.
New York Mortgage Trust (NYMT) Beats Q3 Earnings Estimates
by Zacks Equity Research
New York Mortgage Trust (NYMT) delivered earnings and revenue surprises of 550% and 8.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Invesco Mortgage Capital (IVR) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Invesco Mortgage Capital (IVR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
AG Mortgage Investment Trust (MITT) to Report Q3 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
AG Mortgage Investment Trust (MITT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Invesco Mortgage Capital (IVR) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Invesco Mortgage Capital (IVR) reachead $8.31 at the closing of the latest trading day, reflecting a -1.66% change compared to its last close.
Analysts Estimate Invesco Mortgage Capital (IVR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Invesco Mortgage Capital (IVR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Invesco Mortgage Capital (IVR) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Invesco Mortgage Capital (IVR) concluded the recent trading session at $8.41, signifying a -0.59% move from its prior day's close.
Invesco Mortgage Capital (IVR) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Invesco Mortgage Capital (IVR) stood at $8.62, denoting a +1.17% change from the preceding trading day.
Invesco Mortgage Capital (IVR) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Invesco Mortgage Capital (IVR) reachead $8.47 at the closing of the latest trading day, reflecting a +1.32% change compared to its last close.
Invesco Mortgage Capital (IVR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the most recent trading session, Invesco Mortgage Capital (IVR) closed at $9.39, indicating a +0.75% shift from the previous trading day.
Invesco Mortgage Capital (IVR) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Invesco Mortgage Capital (IVR) stood at $9.01, denoting a +1.46% change from the preceding trading day.
Invesco Mortgage Capital (IVR) Laps the Stock Market: Here's Why
by Zacks Equity Research
Invesco Mortgage Capital (IVR) closed at $9.11 in the latest trading session, marking a +0.05% move from the prior day.
Invesco Mortgage Capital (IVR) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Invesco Mortgage Capital (IVR) closed at $8.77 in the latest trading session, marking a +0.92% move from the prior day.
Invesco Mortgage Capital (IVR) Q2 Earnings Beat Estimates
by Zacks Equity Research
Invesco Mortgage Capital (IVR) delivered earnings and revenue surprises of 14.67% and 6.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Horace Mann (HMN) Q2 Earnings Beat Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of 11.11% and 3.27%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ares Commercial Real Estate (ACRE) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of -163.16% and 2.34%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Chimera (CIM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
A lower mortgage rate is likely to have benefited Chimera's (CIM) second-quarter 2024 performance. High funding costs are expected to have been a headwind.
Invesco Mortgage Capital (IVR) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Invesco Mortgage Capital (IVR) stood at $9.15, denoting a +0.11% change from the preceding trading day.
Invesco Mortgage (IVR) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
A high interest rate environment is likely to have weighed on Invesco Mortgage (IVR) in Q2 2024, while lower volatility in the fixed-income market is expected to have improved the book value.
Invesco Mortgage Capital (IVR) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Invesco Mortgage Capital (IVR) settling at $9.14, representing a -0.22% change from its previous close.
Key Factors to Know Ahead of Arbor Realty's (ABR) Q2 Earnings
by Zacks Equity Research
Weakness in the multi-family asset market with lower loan origination is likely to have hurt ABR Realty's (ABR) Q2 earnings, while strength in servicing revenues is expected to have offered support.
Invesco Mortgage Capital (IVR) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
The latest trading day saw Invesco Mortgage Capital (IVR) settling at $9.38, representing a +0.54% change from its previous close.